IMPULSE(SZ:002899) Shang Hai Zheng Quan Bao·2025-12-09 20:10Core Viewpoint - The controlling shareholder of Qingdao Inpaiss Health Technology Co., Ltd., Hainan Jiangheng Industrial Investment Co., Ltd., plans to increase its stake in the company through a combination of bank loans and self-raised funds within a six-month period, aiming to enhance investor confidence and support the company's sustainable development [2][3]. Group 1: Shareholder's Plan - Hainan Jiangheng intends to increase its shareholding by no less than RMB 60 million and no more than RMB 120 million, without setting a price range for the purchase [2][7]. - The increase will occur through centralized bidding and block trading on the Shenzhen Stock Exchange [8]. - The implementation period for this plan is from December 10, 2025, to June 9, 2026, with adjustments if the company's stock is suspended [7][8]. Group 2: Financial Support - China Everbright Bank has issued a loan commitment letter to Hainan Jiangheng, promising a special loan of up to RMB 100 million to support the share purchase [8]. Group 3: Shareholding Status - As of the announcement date, Hainan Jiangheng holds 40,662,000 shares, representing 27.51% of the total share capital, making it the largest shareholder [3]. - There have been no share reduction activities by Hainan Jiangheng in the past six months [5]. Group 4: Compliance and Regulations - The share purchase plan complies with relevant laws and regulations, ensuring that it will not affect the company's stock distribution or control [9]. - Hainan Jiangheng commits to not reducing its shareholding during the purchase period and will adhere to legal requirements [8][9].